Key result
CABG in adults ≤50 years yields an ~82% 15-year survival rate, significantly outperforming older patients.
Why the study?
There are limited data regarding long-term results after coronary artery bypass grafting in young adults.
What are the long-term survival and major adverse cardiovascular event rates in patients ≤50 years undergoing CABG compared to older patients?
Cohort (n=4,086)
Yes
What are the long-term survival and major adverse cardiovascular event rates in patients ≤50 years undergoing CABG compared to older patients?
Answers are grounded in this paper and cite their sources.
Young adults (≤50 years) undergoing CABG have excellent long-term survival that is significantly better than older age groups, with long-term risk driven primarily by myocardial infarction and repeat revascularization.
BACKGROUND: There are limited data regarding long-term results after coronary artery bypass grafting (CABG) in young adults. We performed a nationwide population-based cohort study to analyze long-term survival, major adverse cardiovascular events, and factors associated with elevated risk in young adults undergoing CABG. METHODS AND RESULTS: We included all adult patients ≤50 years of age who underwent primary isolated CABG in Sweden between 1997 and 2013 from the Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) register. Patient data were linked from national Swedish health data registers to create a study database. We identified 4086 young adults with a mean age of 46 years and 18% women. During a median follow-up time of 10.9 years (interquartile range, 6.4-14.1) 490 (12%) patients died. Survival at 5, 10, and 15 years was 96% (95% CI, 95-96), 90% (95% CI, 89-91), and 82% (95%CI, 80-83), respectively, which was significantly better in comparison with patients aged 51 to 70 years and >70 years who underwent CABG during the same period. The cumulative incidence of death or a major adverse cardiovascular event during 17 years after CABG was mainly driven by myocardial infarction or the need for repeat revascularization. The most important risk factors for all-cause mortality were chronic kidney disease, reduced left ventricular ejection fraction, peripheral vascular disease, or chronic obstructive pulmonary disease. CONCLUSIONS: Long-term survival and freedom from major cardiovascular events after CABG was better in young adults than in older patients. Factors significantly associated with an elevated long-term risk of death or adverse outcome were similar to well-known risk factors for older age groups following CABG. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT02276950.
No takes yet. Share an insight, caveat, or question.
Dalén et al. (2015) conducted a cohort in Coronary artery disease requiring CABG (n=4,086). Coronary artery bypass grafting (CABG) at age ≤50 years vs. CABG at age 51 to 70 years and >70 years was evaluated on Survival at 15 years (95% CI 80-83). Young adults aged ≤50 years undergoing CABG demonstrated a 15-year survival rate of 82%, which was better than older patients.
Synapse has enriched 10 related papers. Consider them for comparative context: